Stakeholders to comment on the European Commission’s Report:

The European Commission has adopted a Report on the application of the Regulation (EC) No 1394/2007 on Advanced Therapy Medicinal Products (“ATMP Regulation”). In the report published on March 28, 2014 , the Commission takes stock of the situation of advanced therapy medicinal products in the EU and analyses the impact of the Regulation on advanced therapies.

Please have a look at the reporthttp://ec.europa.eu/health/files/advtherapies/2014_atmp/atmp_en.pdf ) give your opinion and comment on it in our blog.

AGORA is involved here and communicates actively with ISCT, EBMT and EuropaBio. We recognize that many problems especially for academic centers have been acknowledged in the report, matching well with points of concern identified by the FP7 projects ACADEMIC GMP and AGORA.